Dihydrofolate reductase
Top View
- New Targets for an Old Drug
- Pyrimidine Metabolism in Tritrichomonas Foetus (Uracil Phosphoribosyltransferase/Thymidine Phosphotransferase/5-Fluorouracil) C
- 29, 37 Acantholytic Carcinoma, 141 Ac1arubicin, 214 Acquired
- The Effects of ɤ-Glutamyl Hydrolase Modulation on Cancer Treatment and Dna Methylation in Human Cancer Cells
- In Silico Analysis of the Amido Phosphoribosyltransferase Inhibition by PY873, PY899 and a Derivative of Isophthalic Acid
- E2F1 Inhibits Circulating Cholesterol Clearance by Regulating Pcsk9 Expression in the Liver
- Impact of Genetic Variants of RFC1, DHFR and MTHFR in Osteosarcoma Patients Treated with High-Dose Methotrexate
- Genetic Signatures of Differentiation Induced by 1 ,25-Dihydroxyvitamin D3 in Human Colon Cancer Cells
- Supplemental Table 3
- The Extremely Slow and Variable Activity of Dihydrofolate Reductase in Human Liver and Its Implications for High Folic Acid Intake
- Cell Cycle Regulation of Dihydrofolate Reductase Mrna Metabolism in Mouse Fibroblasts (Gene Expression/Overproducing Cells/Nucleic Acid Hybridization) SIDNEY L
- Genomic Instability and Apoptosis Are Frequent in P53 Deficient Young Mice
- The Vitamin D–Folate Hypothesis As an Evolutionary Model for Skin Pigmentation: an Update and Integration of Current Ideas
- Immune and Metabolic Conditions in Patients with Autism Population
- Potential Benefits of L. Acidophilus in Dyslipidemic Rats
- Biosynthesis of Tetrahydrobiopterin by De Novo and Salvage Pathways In
- Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling
- Genetic Ablation of Purine Salvage in Cryptosporidium Parvum Reveals Nucleotide Uptake from the Host Cell